Skip directly to search Skip directly to A to Z list Skip directly to site content Skip directly to page options
CDC Home

CDC Director Blog

Thoughts from CDC Director Tom Frieden, MD, MPH

Share
Compartir

Selected Category: Public Health & Clinical Care Collaboration

The truth about Ebola, US risks and how to stop it

Categories: Health Protection, Public Health & Clinical Care Collaboration

Many have asked questions about the risk of bringing two Americans with Ebola back home to the United States for medical treatment.

Ebola is frightening because it’s so deadly, especially when patients may not have access to basic medical care that can help keep them alive while they fight the illness. This is certainly the case in the three countries in West Africa and in Lagos, Nigeria that are currently fighting Ebola.

There are really two things that have, I am afraid, been confusing in the publicity on Ebola in the past week.

First – is there any effective, proven treatment for Ebola?  

Yes, there is!  It is basic supportive health care, with fluid management, blood and blood product transfusions if indicated, treatment of bacterial super-infections if patients develop these, and general nursing care. With these core, proven, readily deployable interventions, the death rate from Ebola infections can be cut substantially.

 


If there is a patient with Ebola in the U.S., CDC has protocols in place to stop spread of the disease.

 


We hope drugs and vaccines will be available soon. We hope they work, and we hope they can be produced in substantial quantities if they do work. But even if they do work and even if they are available, they would be supplements to, not replacements for, the basic supportive care that is already proven to work. Unfortunately, this supportive care is not in place today for many of the patients who need it in West Africa and Nigeria, and addressing that need is the top global priority.

The Ebola Outbreak: The CDC Director’s Guidance for Health care workers

Categories: Health Protection, Public Health & Clinical Care Collaboration

Dr. Tom Frieden PhotoTwo Americans who became infected with Ebola virus disease in Liberia are now at Emory University Hospital in Atlanta. They’re receiving supportive care, including careful fluid management, as their bodies wrestle with the Ebola virus. While there is no cure for Ebola, strong supportive care will increase their chances of survival.

Their arrival was carefully planned and prepared for. And their care is being closely monitored as they are being managed in strict isolation. We are confident everything is being done for their well-being, and for the safety and well-being of those treating them.

How did these and other health care workers come down with Ebola virus disease?

We may never know the precise source of their exposure.

Regardless, the occurrence of Ebola virus infection in health care workers is a sobering reminder that the preparedness of health care personnel is often a significant factor in Ebola outbreaks. Isolation and strict infection control procedures are essential to prevent spread of the disease.

Where Are The Hot Spots For Antibiotic Resistance?

Categories: Health Protection, Public Health & Clinical Care Collaboration

 Antibiotic Resistance

This post originally appeared in The Health Care Blog.

In July, CDC will roll out a new way every hospital in the country can track and control drug resistant bacteria. CDC already operates the National Healthcare Safety Network (NHSN), with more than 12,000 health care facilities participating. Now we are implementing a breakthrough program that will take control of drug resistance to the next level – the Antibiotic Use and Resistance (AUR) reporting module. The module is fully automated, capturing antibiotic prescriptions and drug susceptibility test results electronically.

A Better Way to Cure What Ails Us

Categories: Health Protection, Public Health & Clinical Care Collaboration

Blood Pressure Screening

This post originally appeared in the Los Angeles Times.

Annual spending on healthcare in America totals nearly $9,000 per person, accounting for more than 17% of the U.S. economy. Yet, on some of the most basic medical interventions, we’re failing.

Save Our Miracle Drugs

Categories: Health Protection, Public Health & Clinical Care Collaboration

Tablets

This post originally appeared in the Chicago Sun-Times.

The Chicago Sun-Times recently reported on proposed federal legislation to develop an innovative strategy for combating antibiotic resistance. The bill was introduced by two Chicago-area representatives, Peter Roskam and Danny Davis.

Combating antibiotic resistance — bacteria outsmarting the drugs designed to kill them — is critical now, as these microbes could return us to the time when there were no antibiotics and simple infections were fatal.

Older Posts Newer Posts

Pages in this Blog
  1. 1
  2. [2]
  3. 3
  4. 4
  5. 5
 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #